Chinese pharmaceutical companies are gearing up a foray into Africa with multibillion-yuan investments in local drugmaking facilities, lured by the unmet health care needs of the world's fastest-growing and most underserved continent.
Foothold on the continent could give them sway in setting global standards

Building a presence in Africa will help China's independently developed pharmaceutical products to enter the global market.
Chinese pharmaceutical companies are gearing up a foray into Africa with multibillion-yuan investments in local drugmaking facilities, lured by the unmet health care needs of the world's fastest-growing and most underserved continent.